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Abstract
The prevalence of unintended pregnancy among women receiving medication assisted
treatment (MAT) for opioid use disorder (OUD) exceeds 80%. While much of the existing
literature has focused on the consequences of substance use in pregnancy, few have focused on
the prevention of unintended pregnancy. This study explored barriers and facilitating factors
impacting contraception use among women, ages 18-45, receiving MAT for OUD in Middle
Tennessee.
A cross-sectional survey design was used to describe the women’s sociodemographic and
health characteristics; report their knowledge, attitudes, and behaviors; and to assess if these
variables are associated with current use of contraception. Among survey respondents (N=262;
response rate of 98%), most women were publicly insured (92%), sexually active in the past year
(88.2%), pregnant at least once in their lifetime (97%), and most had experienced at least one
unintended pregnancy (83.6%). Although 60.7% agreed it was important to avoid pregnancy, all
contraception groups had low levels of contraception knowledge.
Consistent voluntary use of reliable contraception, like long-acting reversible
contraception (LARC), can reduce the risk of unintended pregnancy among women with OUD.
Improvement strategies are warranted to ensure women enrolled in MAT for OUD have access
to reliable contraception methods and noncoercive contraceptive counseling to curb the rising
rates of unintended pregnancy and reduce rates of neonatal abstinence syndrome (NAS).
Integrating reproductive health services into MAT programs may support the woman’s
commitment to sustained recovery by promoting continuity of care and reproductive autonomy
while being cognizant of historical trauma and current disparities.
Keywords: contraception, opioid use disorder, substance use disorder, and addiction.

CONTRACEPTION USE IN MIDDLE TENNESSEE
Introduction and Background
While the maternal and fetal impact of drug use in pregnancy has received substantial
research attention, few studies have specifically evaluated the high rates of unintended or
unplanned pregnancy among women of child bearing age with opioid use disorder (OUD)
(Terplan, Hand, Hutchinson, Salisbury-Afshar, & Heil, 2015). Among women with opioid use
disorder (OUD), current literature suggests that unplanned pregnancy rates have been estimated
at 8 to 9 out of every 10 pregnancies, a ten-fold increase when compared to the general
population (Black & Day, 2016; Drescher-Burke, 2014; Guttmacher Institute, 2019; Heil et al.,
2011; Robinowitz et al., 2016; Wellings et al., 2013). Without publicly funded programs
designed to help millions of women avoid unintended pregnancies, the rates of unintended
pregnancy would be much higher (Guttmacher Institute, 2019).
Irregular patterns of contraception use, complicated by social determinants of health,
poor access to and utilization of women’s health services, infrequent sexual activity, and
insufficient knowledge on the various contraceptive methods and their associated side effects
have been identified as reasons for the elevated rates of unintended pregnancy among women
with OUD (Black et al., 2012). Given contraceptive use is a vital component in controlling
unplanned or unintended pregnancy, it is important to understand the factors and conditions that
drive the use of contraceptives among opioid addicted women of childbearing age (Centers for
Disease Control and Prevention, 2015).
In 2018, the state of Tennessee implemented several strategies to combat the growing
complexity of opioid abuse and unintended pregnancy in Tennessee. An action plan was
warranted in 2000 after the number of fetus’ exposed to opioids in Tennessee rose from 0.7 to
5.1 per 1,000 births; a rate nearly three times the national average (Erwin, Lindley, Meschke, &
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Ehrlich, 2017; Miller et al., 2017; Patrick et al., 2015). One strategy pertinent to this scholarly
project is to remove barriers for voluntary long-acting reversible contraceptives (LARC) for
women with opioid use disorder as a means to avoid unplanned pregnancy among women with
OUD (TennCare, 2018). However, the barriers and facilitating factors that drive contraception
use among women with OUD have not yet been fully studied. Therefore, this study sought to
identify and describe the barriers and facilitators impacting contraception use among women of
child-bearing age receiving MAT in Middle Tennessee.
Review of Evidence
Sociodemographic Risk Factors
The highest unintentional pregnancy rates are documented among women who are young,
low-income, publicly insured, cohabitating, of minority descent, and without high school
degrees. These socio-demographic characteristics coincide with those of women with an OUD
who experience particularly high rates of unintended pregnancy (Black et al., 2012; Matusiewicz
et al., 2017). In contrast, the lowest unintended pregnancy rates are among women of higher
incomes, white, married, and college graduates (Black & Day, 2016; Guttmacher Institute, 2019;
Hanson, Northwehr, Yang, & Romitti, 2015; Heil et al., 2011; Matusiewicz, Melbostad, & Heil,
2017; Wellings et al., 2013).
Socio-demographic factors such as age, ethnicity, insurance, marital status, educational
attainment, and annual income have been identified as key factors affecting a woman’s ability to
receive family planning services to prevent unintended pregnancy (Black et al., 2012; Black &
Day, 2016 Clergue-Duval et al., 2017; Heil, Gaalema, & Herrmann, 2012; Robinowitz et al.,
2016). In 2011, the unintended pregnancy rate among women with an income below the federal
poverty line was five times greater (112 per 1,000) than those with an income of 200% (20 per
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1,000) over the poverty line (Finer & Zolna, 2016). Further, rates of unintended pregnancy and
adverse reproductive health outcomes are highest among low-income minority women
(American College of Obstetrics and Gynecologists [ACOG], 2015). Because race/ethnicity and
socioeconomical status (SES) are often correlated in the United States, race/ethnicity was a
predictor of unintended pregnancies within each racial/ethnic group (Dehlendorf, Ridriguez,
Levy, Borrero, & Steinauser, 2010; Guttmacher Institute, 2019; Heil et al., 2012; World Health
Organization [WHO], 2007).
Low-income women face barriers to contraceptive access due to insurance status.
Further, lack of insurance is a major risk factor for non-use of prescription contraceptives
(Dehlendorf et al., 2010; Heil et al., 2012). Some of the most effective contraceptive methods,
such as an intrauterine device (IUD) or implant, are unfortunately the most expensive, costing an
individual up to one month’s salary at a minimum-wage job (Guttmacher Institute, 2019;
Hatcher, Zieman, Allen, Lathrop, & Haddad, 2017). With the expansion of the Affordable Care
Act, the cost barrier to contraception was nearly eliminated for women covered by either public
or private insurance. However, women’s awareness of this new access to contraception is unclear
(Chuang et al., 2015).
Reliable Contraception Access
In order for women receiving treatment for substance use disorder to access contraception
services, a number of barriers must be overcome. These barriers include: inaccurate perception
that MAT will consistently impair fertility; misinformation or poor knowledge about the
suitability of different birth control methods; difficulty using conventional healthcare systems;
mistrust of health care services; fear of forced treatment; guilt, denial, or embarrassment
regarding their substance use; stigma; and expense (Armstrong et al. 1999; Black et al., 2012;
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Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Howell & Chasnoff, 1999; Morse,
Ramesh, Jackson, 2017; Terplan et al., 2015; Wellings et al., 2013). As a result, contraception
use among women with SUDs is markedly lower than the general population, which may be
attributed to barriers faced by the woman seeking services or attributed to reproductive health
topics not being addressed when care is sought (Armstrong et al., 1999; Black & Day, 2016,
Clergue-Duval et al., 2017; MacAfee, Harfmann, Kolenic, & Dalton, 2017; Terplan et al., 2015).
Integrating reproductive health services into treatment programs may be an effective intervention
for women at risk for unplanned pregnancy (Black et al, 2012; Frost, Lindberg, & Finer, 2012;
Guttmacher Institute, 2019; Terplan et al., 2015).
Substance abuse treatment programs which provide a range of services to meet the needs
of complex patients are more appealing and acceptable to the patients (Olsen, Banwell, &
Madden, 2014). Since women in substance abuse treatment programs are in regular contact with
a health care provider, incorporating family planning services into their treatment is reasonable
(Terplan et al., 2015). Consistently, women are highly interested in integrating family planning
services into their substance abuse treatment programs, as it is a familiar environment many
perceive to be less threatening since they are typically being treated by a known and trusted
provider (Black et al, 2012; Black & Day, 2016; Heil et al., 2012; MacAfee et al., 2017;
Robinowitz et al. 2016). If reproductive health services are offered in conjunction with SUD
treatment, not only may the risk of unplanned pregnancies and substance-exposed pregnancies be
reduced, but it may also improve the quality of life for the women in treatment programs (Black
& Day, 2016; Heil et al., 2011; Heil et al., 2012; Robinowitz et al.,2016; Terplan et al., 2015).
By increasing women’s knowledge of various contraceptive methods and reducing the financial
barrier to access, studies report women are more likely to choose a significantly more reliable
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method of contraception such as a LARC (Black & Day, 2016; Secura, Allsworth, Madden,
Mullersman, & Peipert, 2010).
Accurate Contraception Knowledge
In previous research, a significant knowledge gap was discovered when assessing
contraception knowledge, attitudes, and beliefs among women receiving MAT. Numerous
misconceptions, inaccuracies, and areas of uncertainty about various birth control methods and
their side effects impact a woman’s choice to use contraception (Robinowitz et al., 2016).
Reported misconceptions included: menstrual irregularities; weight gain; miscarriage;
fearmongering; low pregnancy risk related to MAT; falsified significant adverse effects; and
ineffectiveness (Black et al., 2012; Robinowitz et al., 2016). These misconceptions or false
beliefs may be the result of insufficient knowledge about various contraceptive methods (Black
et al., 2012; Black & Day, 2016; Frost et al., 2012; Robinowitz et al., 2016).
Individuals’ knowledge of various contraception methods, benefits, and potential side
effects is often based on personal experience or information learned from others, not information
learned from a health care provider (Robinowitz et al., 2016). This is particularly important since
the efficacy of many forms of birth control heavily relies on the users’ knowledge and
compliance. Nearly 18% of women at risk of pregnancy who use contraception inconsistently
and/or incorrectly account for 41% of all unintended pregnancies (Guttmacher Institute, 2019).
Although user compliance is a significant factor towards birth control efficacy, it is important to
note two thirds of women in the United States at risk for unintended pregnancy use
contraceptives consistently and correctly (Guttmacher Institute, 2019). However, these women
only account for approximately 5% of all unintended pregnancies (Guttmacher Institute, 2019).
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Although contraceptives are widely used across the world, many women face significant barriers
accessing contraception to meet their reproductive health needs.
If family planning services are integrated into substance abuse treatment programs, health
care providers have the opportunity to educate patients on the various methods and proper use of
birth control, as well as correct any misconceptions or false beliefs (Black & Day, 2016; Hanson
et al., 2015; Heil et al., 2011; Morse et al., 2017; Terplan et al., 2015). However, a knowledge
gap among health care providers can impede their ability to offer accurate information to patients
inquiring about various contraception methods. Many non-obstetrician-gynecologist clinicians
have expressed uncertainty about the risks and benefits associated with LARC methods
(Luchowski et al., 2014). Other barriers to implementation include time constraints, provider
comfort level in discussing family planning services, and provider beliefs that their focus is to
solely treat addiction-specific issues (Robinowitz et al., 2016). Despite provider reluctance,
improved health outcomes, consistent contraception use, and improved maternal mental health
are well documented when family planning services are integrated into substance abuse
treatment programs (Black & Day, 2012; Niccols et al., 2010; Robinowitz et al., 2016).
According to the World Health Organization (WHO) (2007), low investments in health
services and education slow the societal diffusion of knowledge regarding the use of
contraception. Therefore, researchers specifically working with women of childbearing age with
opioid and other substance abuse disorders stressed the importance of practitioners and
researchers investigating the reasons for using or not using contraception (Black et al., 2012;
Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Terplan et al., 2015). Increased insight
into factors leading to varying patterns of birth control utilization may assist in reduction of
unintended pregnancies and substance-exposed pregnancies (Hanson et al., 2015).

CONTRACEPTION USE IN MIDDLE TENNESSEE

12

Integrating family planning services with substance abuse treatment markedly reduce
substance-exposed pregnancies (Black & Day, 2016; Terplan et al., 2015; Robinowitz et al.,
2016). Fetal exposure to opioids occurs when a pregnant woman uses opioids or MAT drugs
such as methadone or suboxone. However, using MAT drugs such as methadone and suboxone
to regularize prenatal dosing of opioids helps avoid relapse, and improves compliance with
prenatal care among women with OUD (ACOG, 2017a; Lee, 2016). Currently, both medications
are classified as the gold standard treatment option for pregnant women with OUD despite the
associated risk of neonatal abstinence syndrome (NAS) (ACOG, 2017a). Associated effects of
MAT use during pregnancy include: NAS, respiratory distress, low birth weight, feeding
difficulties, sleep disturbances, hyperirritability, and seizures. These complications often result in
extended inpatient stays to monitor and treat the infant after birth (Lee, 2016; Miller, McDonald,
& Warren, 2017; Patrick, Davis, Lehman, & Cooper, 2015; Seligman & Berghella, 2018).
Theoretical Model
The theoretical model guiding the scholarly project is the Theoretical Framework of
Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy (Kaye, Suellentrop, &
Beck, 2009) (Figure 1). Developed by the Guttmacher Institute in consultation with the National
Campaign to Prevent Teen and Unplanned Pregnancy, the model served as a framework in
constructing The Fog Zone: a national survey focused on the factors surrounding unplanned
pregnancy by exploring individuals’ knowledge of contraceptives and reproductive health
behaviors (Kaye et al., 2009). These data produced from The Fog Zone survey enhanced
researchers’ knowledge of evaluating individuals’ navigation of sexual encounters by
considering their risk management and evaluation of consequences following an unplanned
pregnancy (National Center for Family & Marriage Research, 2012).
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The key constructs of the Theoretical Framework of Factors Affecting Contraceptive Use
and Avoiding Unintended Pregnancy include: past behavior, demographic variables, exposure to
contraceptive information, contraception knowledge or misconceptions, beliefs and evaluation of
consequences, perceived social norms, intention, self-efficacy, and behavior. The framework’s
constructs mimic the constructs in the Theory of Reasoned Action (TRA) and its extension the
Theory of Planned Behavior (TPB). Similar to the TRA and TPB, the Theoretical Framework of
Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy hypothesizes a
favorable attitude and subjective norm, in combination with greater perceived control or selfefficacy, will result in a strong intention to perform a particular behavior (Ajzen, 1991). Figure 1
provides a visual representation of all direct and/or indirect relationships between constructs and
the likelihood a specific behavior will occur (Kaye et al., 2009).
Behavior is reasoned in the sense that intention, social norms and self-efficacy play a
direct role in determining whether contraception is utilized by an individual (Kaye et al., 2009).
Intention is a cognitive representation of an individual’s readiness to perform a behavior and is
considered to be the single best predictor of behavior (Ajzen, 1991; Montano & Kaspryzyk,
2015). A woman’s intention is directly influenced by the following variables: subjective and
objective knowledge (knowledge and misconceptions), or beliefs about the likely outcome if
utilizing birth control and the evaluation of potential outcomes or consequences of not using
birth control (beliefs and evaluation of consequences); beliefs about the normative expectations
of family, friends, and their partner regarding birth control use and the motivation to comply
with these expectations (subjective norms); and beliefs about the presence of facilitators may
help or hinder using birth control and the perceived power of these factors (self-efficacy) (Ajzen,
1991; Hanson et al., 2014; Montano & Kaspryzyk, 2015).
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Personal experience is also suggested as a powerful predictor of behavior. Failure or
success of past behavioral attempts signals whether the individual believes they can carry out a
behavior (Yzer, 2012). The power of personal experience is also reflected in past behavior, as it
encompasses an individual’s history of drug use and their reproductive health history behaviors
(Kaye et al., 2009). Assessing each person’s past drug use and birth control behaviors provides a
better understanding of the reproductive health needs of the individual. Further, collectively
assessing these two behaviors allows for a better understanding of the myriad of effects
substance abuse can have on a woman’s sexual health including: patterns of contraception,
irregular menstrual history, sexual abuse, and increased risk of sexually transmitted disease
(Black et al., 2012). It is possible that a woman’s poor sexual health (behavior) is a result of the
effects of substance use, social determinants of health (sociodemographic variables), and poor
access to reproductive health services (exposure to information) (Black et al., 2012; Hanson et
al., 2014; Kaye et al., 2009). Therefore, evaluating each theoretical construct may produce
stronger, more nuanced results.
The Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding
Unintended Pregnancy framework was used in this scholarly project, as it is a comprehensive
framework for understanding individuals’ capacities and motivations to avoid unplanned
pregnancy. Although survey measures were available for all theoretical constructs except
intention, it was not feasible to assess the entire model (Table 1). For this scholarly project, past
behavior and the sociodemographic characteristics of the sample were described. Next,
individuals’ objective and subjective knowledge and attitudes of contraception and their
evaluation of consequences of using or not using contraception, which theoretically influence the
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behavior of contraception utilization were explored. The constructs considered are highlighted in
red in Figure 1.
Project Design
A cross-sectional survey design was used for this scholarly project to describe the
women’s sociodemographic and health characteristics; report their knowledge, attitudes and
behaviors; and assess if these variables are associated with current use of contraception. This
study is patterned after an earlier study, performed in Knox County, Tennessee, which also used
a cross-sectional survey design, was descriptive in format, and addressed the association of birth
control related knowledge and attitudes with contraception use (Meschke, McNeely, Brown, &
Prather, 2018). The data used for this scholarly project was collected between September and
December 2018 at Rapha Centre in Manchester, Tennessee and was deidentified for patient
protection. The Institutional Review Board of the University of Tennessee, Knoxville approved
the original study, and project exemption was verified by Belmont University’s Institutional
Review Board (IRB).
Clinical Setting
Primary data was obtained from women, ages 18-45, seeking treatment for opioid
dependency at the Rapha Centre, located in Coffee County, TN. The Rapha Centre specializes in
treating patients with opioid-dependency using the following strategies: to provide specific
mental health therapies unique to the patients’ needs, to closely monitor medical care to promote
and ensure compliance, to utilize the 12-step recovery tools to overcome addiction, and to
perform routine drug screenings to improve patient accountability (Rapha Centre, 2018). At
Rapha Centre, a multi-disciplinary approach is utilized to incorporate both holistic healing and
MAT therapy using FDA approved drugs containing buprenorphine, naloxone, and/or naltrexone
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(Rapha Centre, 2018). The Rapha Center team is composed of two physicians, one nurse
practitioner, eight masters prepared therapists, three nurses, and two medical assistants.
In 2017, Tennessee had a total of 12 licensed opioid treatment programs designed to
provide MAT (Sycamore Institute, 2017). However, only 3 of the 12 programs were located
outside of Nashville (Sycamore Institute, 2017). Rapha Centre currently provides treatment
services to individuals from 26 counties across Middle Tennessee (Figure 2). Uniquely, they are
one of the only OUD treatment facilities in Middle Tennessee that accepts TennCare and
Medicare, in addition to private insurance, for treatment services. To this author’s knowledge,
the next closest facility also accepting TennCare for outpatient addiction treatment services is
greater than 100 miles away.
Project Population
Currently, approximately 466 patients enrolled at the Rapha Centre, of which, 272 are
female. For this scholarly project, the study sample consisted of 262 women, ages 18-45 years,
currently enrolled in Rapha Centre’s MAT program. Convenience sampling method was used for
patient participation. Recruitment occurred three days per week, from 7:30am to 5:00pm.
Individuals were eligible to participate in the study if they were (1) female, (2) between 18 and
45 years of age, (3) were receiving MAT at Rapha Centre from September to December 2018,
and (4) were willing to participate. All males, women under the age of 18 or over the age of 45,
and any individual not receiving MAT at Rapha Centre at the time of the study were excluded.
Sources of Data and Data Collection Instruments
Survey items utilized in the original study were obtained to maximize comparability
across populations (Meschke et al., 2018). When possible, the original author compiled survey
questions from previous studies to create the 58-item survey (Meschke et al., 2018). Permission
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was obtained to use the 58-item survey for this replication study. Rapha Centre physicians, Dr.
Rene del Valle and Dr. Carla Lee, reviewed and approved the survey for face and content
validity. The original survey included measures designed to describe the socio-demographics,
health status and drug use, reproductive health outcomes and behaviors, and reproductive
knowledge and attitudes of the female participants (Table 1). Measures requiring calculation or
coding and other measures used to obtain the above-mentioned measures are described in the
following sub-sections (Table 2). The complete survey is in Appendix A.
Sociodemographic Variables. Sociodemographic variables obtained from the survey
included the following: age, zip code and county of residence, race/ethnicity, marital status,
highest level of education, employment status, insurance coverage, household income, number of
persons living in household, whether the individual has had any difficulty paying rent or utilities
in the past year, and whether the individual has had to move in with family or friends. Age was
calculated from birth date and the survey completion date. Race/ethnicity was self-selected by
the participants from the following races: American Indian/Alaska Native, Asian, Black or
African American, Hispanic/Latino, Native Hawaiian/Pacific Islander, White, or other.
Employment status was determined by the following: full time, part time, temporary,
unemployed – looking for employment, unemployed – not looking for employment, student,
retired, homemaker, unable to work, or other. These nine employment status options were
recoded to reflect employed, unemployed, or not in the labor force. All other socio-demographic
variables utilized in this project are included in Appendix A.
Health Status and Drug Use. Health status variables obtained from the survey include:
general health, depressed mood, date of last normal menstrual cycle, sexual activity, ever having
nonconsensual sex, ever having been physically abused, ever having experienced physical abuse

CONTRACEPTION USE IN MIDDLE TENNESSEE

18

by romantic partner, or if any children have been in DCS custody. Depressed mood was
calculated as the mean of four questions adapted from the Center for Epidemiological Studies
Depression Scale. (α=.68) (Radloff, 1977). Participants reported how often over the past week
they felt depressed, felt everything they did was an effort, felt hopeful about the future (reversecoded), and felt happy (reverse coded; 1 = “rarely or not at all” to 4 = “most of the time”).
Higher mean scores were indicative of higher levels of depressed mood.
Variables assessed in regard to drug use included: duration of MAT treatment, number of
times each individual had completed intake for treatment services, types of substances used in
the past, which opioid was used initially, age at first opioid, how the opioid was taken, how they
obtained the opioid, and whether or not they use cannabis products, cigarettes, smokeless
tobacco, or e-cigarettes. Years since first opioid was calculated from date of survey, birthdate,
and age at first opioid use. All other health status and drug use variables utilized in this project
are included in Appendix A.
Reproductive health outcomes and behaviors. Participants were asked about their
current birth control use, birth control methods used in the past five years, and reasons for not
using or not scheduling appointments to obtain birth control (e.g. bilateral tubal ligation [BTL]).
Women were asked to select all methods they were using at the time of survey completion.
Responses were further categorized into three groups based on their responses to questions asked
about contraception use: (1) BTL, (2) using contraception, and (3) not using contraception. If
women selected “none – tubes tied or hysterectomy” for any of the three questions, they were
categorized in the BTL group. Women who selected “spermicides,” “rhythm method,”
“douching,” “none – currently trying to get pregnant,” “none - do not wish to get pregnant,” and
“none – do not use birth control” were categorized as not using contraception. Women were
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identified as using contraception if they reported current use of the following methods: condoms,
oral contraceptive pills, the patch, Depo, the NuVa ring, IUD or Mirena, a diaphragm, implant,
and/or partner had a vasectomy.
Women identifying as pregnant were placed into a separate category. A woman was
classified as having ever been pregnant if she indicated experiencing one or more pregnancies,
births, miscarriages, or abortions. Total number of pregnancies was calculated as the sum of total
pregnancies, regardless if the mother ever had a miscarriage, abortion, or if the child was still
living. The number of unplanned pregnancies was calculated by subtracting the total number of
planned pregnancies from their total number of pregnancies. All other reproductive health
variables utilized in this project are included in Appendix A.
Reproductive knowledge and attitudes. Reproductive knowledge and attitudes
variables were assessed through a variety of questions answered using a 5-point scale (1 =
“strongly disagree” to 5 = “strongly agree”). Knowledge and attitudes of NAS risk among
participants was measured using a subset of four questions. The author of the original study
adapted these questions from a study used to evaluate women’s knowledge and attitudes
regarding alcohol consumption during pregnancy (Meschke et al., 2018; Peadon et al., 2010).
Higher mean scores were indicative of poor knowledge of NAS. Contraception knowledge was
measured as the percent of 27 true/false questions answered correctly. A subset of 6 of the 27
knowledge questions were used to specifically examine participants’ knowledge of LARCs.
Social support was measured by four questions (α=.68) assessing the woman’s comfort level in
discussing contraception with their doctor and partner (Ong, Temple-Smith, Wong, McNamee,
& Fairley, 2012). In addition, women were specifically asked whether or not their partner and
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friends supported their decision to use contraception. All other reproductive knowledge and
attitudes variables utilized in this project are included in Appendix A.
Data Collection Process & Procedures
All data collection took place three days per week, from September to December 2018.
The principal investigator invited 266 eligible women to participate in the survey when they
arrived at the clinic for treatment services using the letter of invitation. Voluntary consent was
obtained based on acceptance to participate. A total of 262 participants granted consent and
completed the paper survey while waiting to meet with their therapist and/or while waiting to
meet with their provider. Completion of all survey measures was typically 15-20 minutes. The
principal investigator was available to all individuals requesting assistance with completing the
survey. Participants returned the completed survey to the principal investigator prior to
conclusion of the treatment visit. Participants completing the survey had the option to be entered
into a drawing for a $200.00 VISA gift card; the drawing took place on December 12, 2018 at
Rapha Centre.
All data collected was coded, transcribed, and stored into Qualtrics by the principal
investigator. The concise dataset was then exported to IBM SPSS statistical analysis software to
be analyzed. Extra care was taken in evaluating and calculating missing responses. Because there
was no discernible pattern of missingness, all 262 cases were used in the analysis in order to
maintain the robustness of the sample size. In the presentation of descriptive statistics, a category
for “no response” was included.
Statistical Analysis
The Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding
Unintended Pregnancy framework was used to guide organization and analysis of the survey
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results. Themes identified in the results were organized using the frameworks constructs
including: past behavior, socioeconomic and demographic factors, objective and subjective
knowledge and misconceptions, beliefs and evaluation of consequences, and behavior.
Identification of such themes to better understand the barriers and facilitating factors of
contraception use, helped identify potential knowledge gaps and areas of improvement as they
relate to increasing contraception among the sample population.
The characteristics of the sample were described using means and standard deviations for
the continuous measures and frequencies and percentages for the categorical measures. Similar
to the study by Meschke et al., (2018), chi-square or one-way ANOVA were used to explore
associations between contraception and pregnancy status or experiences of women, with
significance determined at p<.05. Bonferroni post hoc tests followed significant chi-squares and
ANOVA models on variables that were significant in East Tennessee. Given the descriptive
nature of the study and the sample size of each contraception group, the level of significance was
not adjusted for multiple comparisons. Adjusting the level of significance and/or conducting
multiple comparisons could potentially increase the risk of a type II error (Perneger, 1998).
Further, Bonferroni adjustments are not suggested when assessing evidence about specific
hypotheses due to the likelihood of committing a Type II error (Perneger, 1998).
Results
Sociodemographic Characteristics
The 262 study participants resided in 26 counties across Middle Tennessee. The top four
counties represented by women include: Warren (21%; n=55), Coffee (16%; n=42), Rutherford
(8%; n=21), and White (7.3%; n=19). The mean age of all participants was 32.0 years, with over
half of the participants being between 26 and 35 years of age (59.7%; n=157). Almost all were
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white (96%; n=251). Other represented races included African American (3.4%; n=9), American
Indian/Alaska Native (2.3%; n=6), Hispanic/Latino (1.9%; n=5), and Native Hawaiian/Pacific
Islander (0.4%; n=1). Over half had an educational attainment level of high school graduate or
less (55.4%; n=145). One quarter of the participants (27.1%; n=71) had at least some college,
and 7.9% had either completed an associate degree (n=11), a bachelor’s degree (n=4), or at least
some graduate level education (n=6). A third of the women (33%; n=87) reported being single
and most had at least one child at the time of the survey (78.2%; n=205). Sixteen percent (n=43)
reported losing custody of a child to Department of Children’s Services (DCS) at some point.
The majority of participants were struggling socioeconomically. Fewer than one third
(29.4%; n=77) were employed full time and less than a quarter were employed part time or were
working temporary positions (16.8%; n=44). Among those unemployed, 19.5% (n=51) indicated
they were seeking work. Two thirds reported an annual household income of $20,000 or less
(62.2%; n=163). Fewer than one in ten (9.1%; n=24) had household income of $30,000 or more.
Multiple confounding stressors of poverty accompanying low incomes were reported by twothirds (66.4%; n=174) of participants by indicating difficulty paying rent, mortgage, or utilities
in the past year. Further, over a third (36.3%; n=95) had moved in with friends or family because
they had no other housing choice.
Regarding health insurance, the majority of participants were publicly insured by
TennCare (92%; n=241). Sixteen participants (6.1%) reported having private insurance. Only
four participants (1.5%) indicated they were uninsured at the time of the survey. Table 3
provides a full report of the participants’ sociodemographic characteristics.
Health Status and Substance Use
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Age of first opioid use ranged from 12 to 40 years. The majority of the women first
initiated the use of opioids as a late teenager (mean age=19.5). Over half initially accessed
opioids through a personal prescription (56%; n=147). Other modes of initial access indicated by
participants included: friend (22.1%; n=58) or family member’s prescription (19.1%; n=50).
Most (75.6%; n=198) smoked cigarettes daily. A third of women reported using either smokeless
tobacco products or e-cigarettes (33.3%; n=87), and one in five (20%; n=54) reported regular
cannabis use. When asked to rate overall health, nearly half of the women self-identified their
health as good (48.55%; n=127). However, over one third rated their health as poor or fair
(36.6%; n=96).
Depression was measured using a four-point depressed mood scale; a score of 4 indicated
high levels of depressed mood in the past week (See Table 2). The women’s responses ranged
from 1-4, with an average score of 2.3 — equivalent to selecting “sometimes” or “often” for each
measure. A depression score of three or greater, indicating high levels of depression, was
reported by 18% of the women. However, a positive trend was found among the remaining
responses. In the past week the two-thirds of women reported, “rarely” or “sometimes” feeling
depressed (n=181; 69.1%), and “rarely” or “sometimes” felt everything they did was an effort
(n=139; 53.1%). Likewise, half selected either “often” or “most of the time” when asked about
feeling hopeful for the future (n=147; 56.1%). A majority selected “often” and “most of the
time” when describing that they felt happy in the past week (n=161; 61.5%).
When asked about historical sexual trauma, one third of the women (36.6%; n=96)
reported having nonconsensual sex. When reflecting on the past year, one quarter (25%; n=66)
reported experiencing physical abuse from anyone. Nearly one in eight women (12.2%; n=32)
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reported having been physically abused by her romantic partner in the past year. Table 4
provides a full report of the participants’ health status and substance use characteristics.
Reproductive Health Outcomes and Behaviors
The majority of women indicated they were sexually active in the past year (88.2%;
n=231). Most women reported having had vaginal sex without a condom in the past two years
(n=226; 86.3%). Nearly all women reported having been pregnant at least once (97%; n=254),
and over two thirds reported being pregnant three or more times in their lifetime (67.5%; n=174).
Approximately one in seven (14.9%; n=39) reported having an abortion at some point in their
lifetime. Among those who had ever been pregnant, almost half (43.9%; n=115) reported
experiencing at least one unplanned pregnancy in their lifetime. However, when subtracting the
number of planned pregnancies from the total number of pregnancies, the percent of unintended
pregnancies among surveyed women was significantly higher. Through calculation, 83.6%
(n=219) of the women had experienced at least one unintended pregnancy in their lifetime. The
total number of pregnancies identified as unplanned ranged from 0-16 (mean = 2.4). More than
one in eight (13.2%; n=34) reported having never experienced a planned pregnancy. One third
(30.6%; n=80) had experienced an unplanned pregnancy while using some form of birth control.
Oral contraceptive pills (49.3%; n=68) were cited most often as the method of contraception
being used when the pregnancy occurred.
Women were asked to report on their current contraception status and to indicate which
methods were being used at the time of the survey. Only methods selected by ten or more women
were included for analysis. Due to high failure rates, contraception use did not include the
following methods: withdrawal, douching, or rhythm methods. Slightly more than a third of the
women (34%; n=90) reported surgical sterilization as their current form of contraception. Among
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the remaining participants, 27.2% (n=72) reported currently using contraception, 26% (n=69)
reported no current contraceptive use, and 12.8% (n=31) were currently pregnant at the time of
survey. Among the women not currently pregnant, not surgically sterilized, and not actively
trying to get pregnant (n=72), 9.6% (n=16) reported using oral contraceptive pills, 7.8% (n=13)
reported using Depo Provera, and 7.2% (n=12) reported using condoms as their current
contraceptive method of choice. The majority of women reported their current form of
contraception as hysterectomy/BTL (53.9%; n=90). Among the remaining women using
contraception, few utilized a LARC as their current method of contraception – Implant (7.2%;
n=12) and IUD (6.6; n=11).
Birth control methods used in the past five years were also examined. Similar to current
form of contraception, only methods selected by ten or more women were used in the analysis.
The number of contraception methods used in the past five years ranged from 1 to 10 (mean =
1.7). Condoms were identified as the most common form of contraception used in the past five
years (27.1%; n=71), followed by hysterectomy/BTL (26%; n=68), oral contraceptive pills
(24%; n=63), and Depo Provera (22.1%; n=58). Similar to the low rate of LARCs used as a
current method of contraception, few women reported using LARCs over the past five years
when compared to other methods – IUD (10.3%; n=27) and Implant (9.5%; n=25).
Participants’ responses regarding reasons for not using contraception in the past year and
reasons for missing or not making an appointment for birth control were also evaluated. The
most cited reason for not using birth control was due to having undergone a BTL and/or
hysterectomy (29%; n=76), or because they were pregnant (29%; n=76). Fewer women reported
not using contraception for the following reasons: it is okay if they got pregnant (8.4%; n=22),
did not think you need to (8%; n=21), difficult to take or have available (6.5%; n=17), and
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missed medical appointment so no prescription (6.5%; n=17). The more frequent reasons for
missing or not making an appointment for birth control included: surgical sterilization (28.2%;
n=74), forgot (12.6%; n=33), and overslept (4.2%; n=11). Less than a quarter (16.4%; n=43)
kept appointment with a healthcare provider in the past year. Table 5 provides a full report of the
participants’ reproductive health outcomes and behaviors characteristics.
Reproductive Knowledge and Attitudes
The participants were asked a variety of questions designed to evaluate their knowledge
and attitudes towards contraception. Contraceptive knowledge was calculated through 26
true/false questions. The women’s score was based on the total number of questions answered
correctly (See Table 2). The percent of true-false knowledge questions answered correctly
ranged from 0% to 89%, with a mean score of 52.6%. The women, on average, answered fewer
than half (45.5%; n=254) of the six true/false knowledge questions specific to LARCs correctly.
Despite low levels of contraception knowledge, two thirds of women (60.7%; n=159) agreed that
it was important to avoid pregnancy.
An additional subset of four questions assessed the women’s understanding of perinatal
risk posed by opioids, specifically NAS risk and concern (Table 2). Higher levels of agreement
indicated greater perceived risk of NAS. Among this sample, there was a high level of
appreciation for the perinatal risk posed by opioid use (mean = 1.75) — equivalent to selecting
“strongly agree” or “agree” for each of the four questions assessing women’s knowledge of
perinatal risk posed by opioids. Table 6 provides a full report of the participants’ reproductive
knowledge and attitudes.
Current Contraception Status Group Differences
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Birth control use and its necessity were used to categorize the women in relation to
susceptibility for unplanned pregnancy while enrolled at Rapha Centre for treatment of OUD.
The first category included those who had undergone surgical sterilization (e.g. hysterectomy
and/or BTL). The second category included women who reported current birth control use (e.g.
condoms, oral contraceptive pills, Depo Provera, the NuVa ring, IUD, a diaphragm, implant,
and/or partner had a vasectomy). The third category included women who were at risk for
unplanned pregnancy by not using contraception, or if they listed an alternative less reliable
method (e.g. spermicides, rhythm method, douching, none – currently trying to get pregnant,
none - do not wish to get pregnant, and none – do not use birth control). A final category was
created specifically for those currently pregnant at the time of the survey. Table 6 displays group
differences between previously published significant variables in East Tennessee and three
categories of contraceptive use — BTL (nmax=90), using contraception (nmax=72), and not using
contraception (nmax=69). Table 7 specifically includes those who were currently pregnant at the
time of the survey (nmax=31).
Group differences regarding sociodemographic characteristics were not assessed due to
previously published insignificant findings in East Tennessee (Meschke et al., 2018). Group
differences were evaluated for depressed mood; however, the evidence was insufficient to make
a conclusion regarding contraception group differences. Initiation of opioids occurred later in life
for the hysterectomy/BTL group compared to groups not using contraception or those currently
pregnant. However, women who reported having undergone a BTL/hysterectomy and those not
using contraception reported a greater number of years since initiating opioid use than women
using contraception and currently pregnant women. Group differences were not evaluated for the
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remaining health status and substance use measures due to previously published insignificant
findings in East Tennessee (Meschke et al., 2018).
For reproductive health, women were asked if it was important to avoid pregnancy.
Evidence to support group differences was significant between women having undergone
BTL/hysterectomy and using contraception. However, the evidence was insufficient to make any
conclusion that would include the women not using contraception. In addition, no conclusion
was made regarding significant group differences between the four contraception groups and the
number of pregnancies or percent of pregnancies that occurred while using birth control.
Nearly all women agreed that pregnant women should not use painkillers, which made it
difficult to distinguish if there was any significant difference between contraception groups.
When evaluating group differences in the percentage of questions on LARCs answered correctly,
a significant difference was found between the women using contraception and women who
reported having a hysterectomy/BTL. Women using contraception indicated higher mean levels
of LARC knowledge than those belonging to the hysterectomy/BTL group. The remaining
knowledge and attitude measures were not evaluated for group differences due to insignificant
findings previously published in East Tennessee (Meschke et al., 2018).
Discussion
This study provides a comprehensive description of women, ages 18-45, enrolled in MAT
across Middle Tennessee in 2018. The findings from this study expand upon previously
published work examining reproductive health knowledge, attitudes, and behaviors among
women enrolled in MAT for OUD in East Tennessee (Meschke et al., 2018). Together, these
findings not only provide descriptive data on the women enrolled in MAT across 42 counties in
both Middle and East Tennessee, but also may provide insight into the factors impacting
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contraception utilization to avoid unintended pregnancy. Both studies utilized the Theoretical
Framework of Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy to
describe the samples’ past behavior and sociodemographic characteristics, and to report on the
subjective and objective knowledge of contraception and attitudes of contraception.
Theoretically, each of the constructs being evaluated predict the utility of contraception to avoid
unintended pregnancy (behavior) (Ajzen, 1991; Hanson et al., 2014; Montano & Kaspryzyk,
2015).
Two questions within the survey were designed to capture unintended pregnancy rates
among women in the sample. First, women selected yes or no when asked if they had ever
experienced an unintended pregnancy. Among women in this sample, 43.9% (n=115) indicated
they had experienced an unplanned pregnancy. Second, women were asked to provide the total
number of pregnancies and total number of planned pregnancies they had experienced. To
calculate the total number of pregnancies classified as unplanned or unintended, the number of
planned pregnancies was subtracted from the total number of pregnancies. A significant
discrepancy was found between the number of women reporting to have experienced an
unplanned or unintended pregnancy and the number of unplanned or unintended pregnancies
determined through calculation. This calculation revealed the number of women having
experienced at least one unintended pregnancy in their lifetime was nearly double (n=219;
83.6%) the rates found in the initial yes/no question. Although the calculated rate of unplanned
pregnancy among women in Middle Tennessee is consistent with the rates among women with
OUD in East Tennessee, these rates are nearly twice that of the general population in Tennessee
and nationally (Guttmacher Institute, 2017; Guttmacher Institute, 2019; Meschke et al., 2018).
However, when compared to unintended pregnancy rates among women with SUD, these
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findings are consistent to those published in the literature (Black & Day, 2016; Drescher-Burke,
2014; Guttmacher Institute, 2019; Heil et al., 2011; Robinowitz et al., 2016; Wellings et al.,
2013).
Socioeconomic Barriers
The sociodemographic and reproductive health characteristics of women in Middle
Tennessee accompanied by the high rates of unintended pregnancy is concerning evidence.
Consistent with the literature, many women indicated they faced a variety of physical and
emotional challenges including poverty, low education, and histories of physical and sexual
abuse (Black & Day, 2016; Heil et al., 2011; Morse et al., 2017). While each of these
characteristics are potential risk factors for experiencing an unintentional pregnancy and
suggestive of a woman’s health and status, they may not accurately capture women’s experiences
or circumstances preceding the pregnancy (Black & Day, 2016; Heil et al., 2011; Guttmacher
Institute, 2019, Morse et al., 2017).
Women living in poverty have particularly high risk for both addiction and unintended
pregnancy (Finer & Zolna, 2016; National Institute on Drug Abuse, 2017). Evidence of poverty
was evident among both samples of women in Middle and East Tennessee receiving MAT for
OUD. Two thirds (62.2%) of women sampled indicated an annual household income of less than
$20,000. Likewise, over two-thirds indicated difficulties paying rent, mortgage, or utilities in the
past year. Although unintended pregnancy rates tend to be highest among low-income women,
socioeconomic factors were not cited as a primary contributor for not using contraception to
avoid unintended pregnancy. Further, more women cited socioeconomic factors as a primary
reason for not using contraception to avoid unintended pregnancy in East Tennessee than in
Middle Tennessee (Meschke et al., 2018). This difference may be associated with more women
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in Middle Tennessee being covered by public or private health insurance than those in East
Tennessee.
Increasing Contraception Knowledge
Low levels of contraception knowledge were reported in both Middle and East
Tennessee. Two-thirds of women in Middle Tennessee indicated it was important to avoid
pregnancy at the time of the survey; however, most reported low levels of contraception
knowledge. Accompanying poor knowledge, women cited various reasons for not using birth
control including: did not think you need to (n=22), method is difficult to remember to take or
have available (n=18), missed appointments (n=17), only occasionally have sex (n=17), and
safety concerns (n=16). Based on these responses, further investigation into the women’s selfefficacy and decision-making processes may be warranted. Likewise, exploring strategies to
improve contraception knowledge may be useful to improve the uptake of more reliable forms of
contraception to avoid unplanned pregnancy.
Of the participating women, 30.6% (n=80) reported at least one pregnancy while using
birth control; most commonly cited methods of use were oral contraceptive pills, condoms, or
Depo-Provera. These failure rates in addition to the low levels of LARC knowledge highlight an
educational opportunity for this population. Using a standardized script explaining LARC
methods to women, while simultaneously offering same-day access to LARCs at reduced or no
cost to women, The CHOICE Project showed significant improvements in LARC uptake among
women at risk for unintended pregnancy (Secura et al., 2010). Piloting projects similar to the
CHOICE Project at treatment facilities may be an effective way to improve access to
reproductive health services for women receiving MAT. Likewise, these projects provide women
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the opportunity to be counseled on various contraceptive methods to enhance their reproductive
autonomy by selecting the method that best meets their reproductive health needs.
Lastly, because our sample contained a large number of women who had undergone a
surgical sterilization, ecological investigations and explorations of decision-making factors
among women who had undergone a BTL/hysterectomy enrolled in MAT are warranted to
improve understanding of their reproductive health needs. One third (34%) of the women in our
study reported having had surgical sterilization (i.e., BTL/hysterectomy). The prevalence of BTL
in this study was consistent with rates reported in other studies of women with OUD, including
those in East Tennessee (36.9%). However, sterilization rates in this sample far exceeded the
estimate for the general US population. From 2013 to 2015, approximately 22% of women in the
United States, aged 15-44, had undergone surgical sterilization (Kaiser Family Foundation,
2018). One could speculate that these women have already obtained the goal of having children;
however, additional research on the decision-making strategies of women who have undergone a
BTL/hysterectomy could help achieve more effective support for women considering surgical
sterilization.
Initiatives Promoting Contraception Access and Utilization
Although Tennessee opted out of the ACA Medicaid expansion, the state’s public
insurance TennCare has prioritized improving access to reliable contraception for women with
OUD. One of TennCare’s strategies specifically aims to reduce barriers to LARC access
(TennCare, 2018). Additional measures designed to improve access and to increase uptake of
LARCs among women with OUD receiving MAT include the expansion of Tennessee Medicaid
reimbursement for immediate post-partum LARC insertion (i.e. IUD or implant) (ACOG,
2017b). The purpose of the expansion was to reduce barriers and improve access to LARCs for
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women with OUD receiving MAT by improving reimbursement for healthcare providers
(ACOG, 2017b). Additional research is needed to make a conclusion on the program’s success.
On a national level, The Substance Abuse and Mental Health Service Administration
(SAMSHA) recently revised their Opioid Treatment Program (OTP) Guidelines. The guidelines
recommend that OTPs provide reproductive health education for all patients and, when needed,
make appropriate referrals for contraceptive services (SAMSHA, 2015). These recommendations
stress the importance of enhancing reproductive health education and services for women
enrolled in MAT. If an OTP is unable to integrate reproductive health services into their existing
treatment program, SAMSHA encourages OTPs collaboration with local health care providers,
local public health departments, or community health centers as a strategy to meet the
recommendation of improving access to reproductive health services for the women being served
(SAMSHA, 2015). Expanding access and treatment programs to include family planning
services may help reduce financial and knowledge barriers related to effective contraception.
Implications for Practice
This study provides insight on the barriers and facilitating factors that influence a
woman’s decision to utilize contraception. The findings from this study may be helpful in
exploring ways to improve the uptake of more reliable forms of contraception among women
with OUD not using contraception or who are using less reliable methods. By increasing
women’s knowledge of various contraceptive methods and reducing financial barriers, studies
report women are more likely to choose a significantly more reliable method of contraception
such as a LARC (Black & Day, 2016; Secura et al., 2010). More specifically, over 70% of
women chose a LARC method after contraceptive counseling was provided and financial barriers
were reduced (Black & Day, 2016; Secura et al., 2010).
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Successful SUD treatment programs clearly communicate the benefits of effective
contraception to women, while also offering same day services with skilled providers to reduce
barriers to access (Black & Day, 2016). Therefore, the findings from this study could be used to
inform treatment programs of the benefits associated with integrating reproductive health
services into treatment programs. For treatment programs that have not integrated reproductive
health services, collaborations with local health departments or community health centers may
enhance the accessibility of comprehensive family planning services, reduce costs, and improve
uptake of reliable contraceptive methods. If reproductive health services are readily available for
women receiving MAT for OUD, not only may the risk of unplanned pregnancies and substanceexposed pregnancies be reduced, but the quality of life for the women in treatment programs may
also be improved by facilitating self-efficacy by planning for the family size of their choice
(Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Robinowitz et al.,2016; Terplan et al.,
2015).
Strengths and Limitations
The study provides unique and comprehensive insight into the characteristics and patterns
of contraception use of women enrolled in MAT for OUD across Middle Tennessee. These data
provide an extension to the previously published findings in East Tennessee. Despite this study’s
contributions of gaining a better understanding of the barriers and facilitators impacting
contraception use among women receiving MAT across Tennessee, the individual and combined
results must be interpreted and used cautiously.
The first limitation to this study is the survey used had not been previously validated.
Using a validated tool would have improved the validity and reliability of this study. Second, this
replication study was designed to determine whether or not the reported barriers and facilitators
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of contraception use among women enrolled in MAT in East Tennessee could be generalized to
women currently enrolled in MAT in Middle Tennessee. Since regional differences were found,
generalizability cannot be assumed. Likewise, it is unknown whether findings from either study
would adequately describe women receiving MAT in Western Tennessee or other surrounding
states. Additional research in regions not described in either study is needed to obtain a more
complete picture of the reproductive health challenges experienced by women receiving MAT in
Tennessee. Third, since the women completed the survey independently and no assessment of
the women’s baseline health literacy was performed, the results of the survey may not fully
represent the population. Response errors may have been limited if the survey was administered
to the women with assistance.
There are several strengths to this study. First, this study will contribute to the limited
body of evidence published on preventing unintended or unplanned pregnancy among women
receiving MAT for OUD. Next, this study contained a large sample size and high response rate.
Compared to East Tennessee, few women declined to complete the survey. This study’s higher
response rates may be attributed to women being asked to independently complete the survey.
Since the women completed the survey independently, researcher bias was not considered a
limitation in this study. The risk of bias may have increased had the survey been administered by
the researcher. Lastly, the risk of data input errors was reduced due to the primary investigator
independently transcribing the data from the original paper copy into Qualtrics. To ensure no
errors were made during the transcription process, the primary investigator performed an audit
on 20% of the transcribed surveys.
Conclusion
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This study, an extension of a previously published study that provided a comprehensive
description of women aged 18–45 enrolled in MAT in East Tennessee in 2015, support those
findings while also contributing to the limited body of evidence available regarding barriers and
facilitating factors to contraception use to avoid unintended pregnancy among women enrolled in
MAT. Because women receiving MAT for OUD experience a number of barriers accessing
contraception services, treatment programs are encouraged to meet the needs of substance-using
women by improving the accessibility to reproductive health services. Improved access to highquality, integrated, reproductive health care that utilizes a multidisciplinary approach for women
with OUD is needed due to the co-occurrence of OUD with multiple socioeconomical, physical,
and emotional challenges. Utilizing a multidisciplinary woman-centered approach towards
family planning not only is cognizant of historical harms or trauma and current disparities
associated with addiction, but also considers and optimizes women’s reproductive preferences.
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Figure 1. Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding
Unintended Pregnancy adaptated from The fog zone: How misperceptions, magical
thinking, and ambivalence put young adults at risk for unplanned pregnancy, by K. Kaye, K.
Suellentrop & C. Beck, 2009, Retrieved from http://www.thenationalcampaign.org/fogzone/

Figure 2. Geographical distribution of Rapha Centre patients

45

CONTRACEPTION USE IN MIDDLE TENNESSEE

Figure 3. The government makes certain that BC is safe before they come onto the market
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Figure 4. Drug companies don’t care if BC is safe, they just want to make money.
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Figure 5. Will get pregnant regardless of BC use.
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Figure 6. You can’t stop to use BC when aroused.
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Figure 7. Using BC is morally wrong.
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Figure 8. Men are more responsible for using BC than women.
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Table 1: Survey questions aligning with theoretical constructs & measures used in data
analysis
Theory Constructs
Survey Questions)
Past Behavior
 General health
 Depressed mood (Table 2)
 Ever had nonconsensual sex
 Ever physically abused
 Physical abuse by romantic partner
 Age of first opioid
 Years since first opioid
 First time in MAT
 Cigarette use
 Marijuana use
 Number of pregnancies
 Number of pregnancies while on birth control
Socio-demographics
 Age
 Zip-code
 Ethnicity
 Marital status
 Education level
 Employment status
 Insurance coverage
 Household income
 Number of persons living in household
 Challenges paying rent/move in with family
Exposure to Information
 Regular women’s health provider
Knowledge, Attitudes, & Beliefs
 Percent answered correctly (T/F) (Table 2)
Evaluation of Consequences
 NAS risk (Table 2)
 Women enrolled in MAT should be required by law to
use long lasting birth control.
Self-efficacy
 Important to avoid pregnancy
 Fate determines pregnancy
 Partner determines use of birth control
Behavior:
 Not using birth control
Contraception Use
 Current birth control use
 Tubal ligation
Behavior:
 Percent unplanned pregnancy
Effective avoidance of unplanned  Unplanned pregnancy (Y/N)
pregnancy
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Table 2 – Calculated measures
Measure
Survey Questions
NAS Risk
 Suboxone use during pregnancy can affect the fetus
(mean)
 Taking prescription painkillers during pregnancy can affect
the fetus.
 Prescription painkillers can create challenges in pregnancy
 Community members are concerned about women using
painkillers during pregnancy.

Depression
(mean)

In the past week - how often have you experienced the
following?
 You felt depressed
 You felt that everything you did was an effort
 You felt hopeful about the future (reversed)
 You were happy (reversed)

Knowledge,  It is okay to use the same condom more than once.
Attitudes &  Condoms have an expiration date.
Beliefs
 When putting on a condom it is important to leave a space at
(% correct)
the tip.
 It is okay to use petroleum jelly or Vaseline as a lubricant
when using latex condoms.
 When using a condom, it is important for the man to pull out
right after ejaculation?
 Wearing two latex condoms will provide extra protection.
 Birth control pills are effective even if a woman misses taking
them for two or three days in a row.
 Women should “take a break” from the pill every couple of
years.
 If a woman is having side effects with one kind of pill,
switching to another type or brand might help.
 Birth control pills reduce the chances that women will get
certain types of cancer.
 After a woman stops taking birth control, she is unable to get
pregnant for at least two months.
 In order to get the birth control pill, a woman must have a
pelvic exam.
 A young woman can use an IUD, even if she has never had a
child.
 Woman who use IUDs cannot use tampons.
 To obtain an IUD, a woman must undergo a surgery.
 An IUD cannot be felt by a woman’s partner during sex.
 IUDs can move around in a woman’s body
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Scale
1. Strongly
Disagree
2. Disagree
3. Neither
Agree nor
Disagree
4. Agree
5. Strongly
Agree
1. Rarely or
not at all
2. Some of
the time
3. Often
4. Most of
the time
True or False
0. Wrong
Answer
1. Right
Answer

CONTRACEPTION USE IN MIDDLE TENNESSEE
 Women using the birth control shot, Depo-Provera, must get
an injection every three months.
 Even if a woman is late getting her birth control shot, she is
still protected from pregnancy for at least 3 months.
 Women using the vaginal ring, or Nuva Ring, must have it
inserted by a doctor or health care provider every month.
 Long-acting methods like the implant or IUD cannot be
removed early, even if a woman changes her mind about
wanting to get pregnant.
 After giving birth, a woman can get pregnant even before she
has her first period.
 Douching (washing the vagina) after sex can prevent
pregnancy.
 A woman who is still breast feeding cannot get pregnant.
 Pregnancy is much less likely to occur if a couple has sex
standing up.
 The only way to completely prevent pregnancy is by not
having sex.
 During a woman’s monthly cycle, there are certain days when
she is more likely to become pregnant if she has hex.
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Table 3 – Sociodemographic characteristics (n = 262)
n (%) / mean  SD
32.0  6.1

Age in years
18-25
26-35
36-45

29 (22)
157 (59.7)
76(28.9)

Single
Living with partner
Married
Separated
Divorced
Widowed

87 (33.2)
74 (28.2)
65 (24.8)
20 (7.6)
15 (5.7)
1 (.4)

< High school
High school diploma
Some college
2yr college
4yr college
Graduate degree
Other

35 (13.4)
110 (42)
71 (27.1)
11 (4.2)
4 (1.5)
3 (1.1)
25 (9.5)

Private
Public
None

16 (6.1)
241 (92)
4 (1.5)

$0 - $10,000
$10,001 - $20,000
$20,001 - $30,000
$30,001 - $50,000
Over $50,000
Don’t know
Not reported

88 (33.6)
75 (28.6)
47 (17.9)
15 (5.7)
9 (3.4)
26 (9.9)
2 (0.8)

Employed
Unemployed
Not in labor force
Not reported
Difficulties paying rent in the past year
Yes
No

120 (45.6)
72 (27.4)
69 (26.2)
1 (0.8)

Marital Status

Education

Insurance

Income

Employment

174 (66.4)
86 (32.8)
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Moved in with family/friends in past year
Yes
No
Not reported

95 (36.3)
163 (62.2)
4 (1.5)

Children in DCS custody
Yes
No
Not reported

43 (16.4)
208 (79.4)
11 (4.2)

None
1 to 3
4 or more

11 (4.2)
205 (78.2)
42 (16)

Number of living children
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Table 4 – Self-reported health status and drug use (n = 262)
n (%) / mean  SD
Rating general health
3.3  0.849
(range: 1-5, n = 259)
Poor
16 (6.1)
Fair
80 (30.5)
Good
127 (48.5)
Very good
28 (10.7)
Excellent
8 (3.1)
Not reported
3(1.1)
Depressed mood
(range 1-4, n = 257)

2.3  0.94

Nonconsensual intercourse
Yes
No
Not reported

96 (36.6)
158 (60.3)
8 (3.1)

Physically abused in last year
Yes
No
Not reported

66 (25.2)
188 (71.8)
8 (3.1)

Physically abused by partner in
last year
Yes
No
Not reported

32 (12.2)
222 (84.7)
8 (3.1)

Source of first opioid
Own prescription
Friend
Family members prescription
Street contact
Other

147 (56.1)
58 (22.1)
50 (19.1)
22 (8.4)
5 (1.9)

Mean age of first opioid
(range 12 – 40; n=238)

19.5 (5.2)

Years since first opioid use
(range 1 – 32; n=238)

12.7 (5.6)
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Number of intakes for MAT
Once
More than one
Not reported

115 (43.9)
92 (35.2)
13 (16.0)

Yes
No
Not reported

198 (75.6)
62 (23.7
2 (0.8)

Cigarette use

Smokeless tobacco use
Yes
No
Not reported

19 (7.3)
240 (91.6)
3 (1.1)

Yes
No
Not reported

68 (26)
191 (72.9)
3 (1.1)

Yes
No
Not reported

54 (20.6)
204 (77.9)
4 (1.5)

E-cigarette use

Marijuana use
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Table 5 – Reproductive health outcomes, knowledge, attitudes and behaviors (n = 262)
n (%) / mean  SD
Sexually active in last 12 mo.
231 (88.2)
Yes
28 (10.7)
No
3 (1.1)
Not reported
Vaginal sex without condom in the last 2 years.
Yes
No
Unsure
Not reported
Birth control methods used in past 5 years: Select
all that apply.

226 (86.3)
27 (10.3)
1 (0.4)
8 (3.1)
1.7  1.2

(items selected by 10 or more women.; range 1- 10)

Condom
Bilateral tubal ligation (BTL) / hysterectomy
Oral contraceptive pills
Depo
Withdrawal
Intrauterine device (IUD)
Implant
NuVa ring
Plan B

71 (27.1)
68 (26.0)
63 (24.0)
58 (22.1)
49 (18.7)
27 (10.3)
25 (9.5)
14 (5.3)
10 (3.8)

Current birth control use
Currently pregnant
Not using birth control
Using birth control
Has a BTL/Hysterectomy
Type of current birth control use Select all that
apply.

31 (12.8)
69 (26.0)
72 (27.2)
90 (34.0)
0.9  0.6

(items selected by 10 or more women; range 1- 3)

BTL/Hysterectomy
Oral contraceptive pills
Depo
Withdrawal
Condom
Implant
Intrauterine device (IUD)

90 (53.9)
16 (9.6)
13 (7.8)
13 (7.8)
12 (7.2)
12 (7.2)
11 (6.6)
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In the past 12 months, have there been times when
you have not used birth control because:
Select all that apply.

1.6  1.3

(items selected by 10 or more women; range 1- 6)

Had BTL or hysterectomy
You were pregnant
It is okay if you get pregnant
You don’t think you need to
Difficult to remember to take or have available
Missed medical appts, so no Rx
Only occasionally have sex
Safety concerns
Have always used birth control in the past 12 mo’s
Reason for missing or not making an appointment
for birth control in the past 12 months: Select all
that apply.

76 (29)
76 (29)
22 (8.4)
21 (8)
18 (6.9)
17 (6.5)
17 (6.5)
16 (6)
13 (5)
0.4  1.2

(items selected by 10 or more women; range 1- 7)

Had BTL or hysterectomy
Forgot
Kept appointment in past 12 mo
Met as scheduled
Overslept
No insurance

74 (28.2)
33 (12.6)
27(10.3)
16 (6.1)
11 (4.2)
10 (3.8)

Yes
No
Not reported

254 (97.0)
4 (1.5)
4 (1.5)

None
1-2
3-4
5+
Not reported

4 (1.5)
77 (29.4)
118 (45.0)
59 (22.5)
4 (1.5)

Yes
No
Not reported

115 (43.9)
92 (35.2)
13 (16.0)

Ever pregnant

Number of pregnancies
Categorical measures
(range 1 – 16; n=262)

Ever had an unplanned pregnancy
(n=238)
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2.43  1.91

Number of pregnancies that were unplanned
(range 0 - 15; n=262)
Categorical measures
None
1
2
3
4+

42 (15.9)
46 (17.4)
53 (20.1)
60 (22.7)
61 (23.4)
0.2  0.8

Number of abortions (range 0-2)
None
1
2
3
Not reported

217 (82.8)
33 (12.6)
5 (1.9)
1 (0.4)
6 (2.3)
2.5  1.3

Number of births (range 0-7)
None
1-2
3-4
5+
Not reported

12 (4.6)
125 (47.7)
103 (39.3)
18 (6.9)
4 (1.5)

Ever become pregnant while using birth control
Yes
No (including never pregnant)
Not reported

80 (30.6)
158 (60.3)
24 (9.2)

Most cited failed method
(n = 138; 1-4 methods selected)
Oral contraceptives
Condoms
Depo-provera
Withdrawal

68 (49.3)
30 (21.7)
29 (21)
11 (8.0)
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Table 6 – Reproductive knowledge and attitudes (n = 262)
Important to avoid pregnancy
(range 1-5)

n
249

1.75  1

Perceived risk of neonatal abstinence syndrome (NAS)
 Suboxone use during pregnancy can affect the fetus
 Taking prescription painkillers during pregnancy can affect
the fetus
 Prescription painkillers create challenges in pregnancy
 Community members are concerned about women using
painkillers during pregnancy.

mean  SD
1.9  1.4

255
253

2.3  1.3
1.7  1.1
1.3  0.7
1.7  0.9

Percent correct on knowledge deficit scale
(27 items; range 0% - 89%)

234

52.6  23.8

Percent correct on knowledge of intrauterine devices
(IUDs)
(6 items; range 0% - 85%)

254

Social support
(4 items; range 1-5)

256

1.5  1.0

The government makes certain that birth control is safe
before they come onto the market. (Figure 3)
(range 1-5)

252

3.2  1.2

Drug companies don’t care if birth control is safe, they
just want people to use it so they can make money.
(Figure 4)
(range 1-5)

251

2.6  1.3

Will get pregnant regardless of birth control. (Figure 5)
(range 1-5)

254

3.3  1.6

You can’t stop to use birth control when aroused.
(Figure 6)
(range 1-5)
Using birth control is morally wrong. (Figure 7)
(range 1-5)

248

2.2  1. 4

249

1.6  1.0

Men are more responsible with birth control than women.
(Figure 8)
(range 1-5)

249

2.0  1.1

253
255

45.5  16.7
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Table 7 – Chi-squared or One-way ANOVA with Bonferroni Post Hoc Test by Current Contraception Status (Maximum n = 256)
Measure

Hysterectomy or
Using
Not using
BTL (1)
Contraception (2) Contraception (3)
Frequency (%) or Mean ± Standard Deviation
Sociodemographic Characteristics

n

Chi-square or
F-Value

p-value

Sig Mean Contrasts

1.4

.237

NOT SIG

Age:
35.8 ± 5.2

29.8 ± 5.3

32 ± 5.6

247

35 (54.5)

28 (55.9)

34 (64.2)

211

22 (25.3)

8 (12.1)

9 (17.3)

205

63 (70)

57 (83.9)

41 (77.4)

211

38 (14.4)

28 (10.6)

26 (9.9)

92

87 (97.7)

66 (97)

53 (100)

210

49 (72.1)
29 (55.8)
Health Status & Substance Use

210

Married/Cohabitating:
Child ever in DCS custody?
Education level greater than H.S.?
Employed fulltime:
Insured
Challenges paying rent
61 (67.8)
General health
3.4 ± 0.8

3.1 ± 0.9

3.2 ± 0.8

242

2.2 ± 0.9

2.0 ± 0.9

2.1 ± 0.9

239

38 (42.2)

21 (30.9)

23 (43.4)

211

21 (23.3)

20 (29.4)

17 (32.1)

211

11 (12.2)

10 (14.7)

7 (13.2)

211

20.9 ± 6.1

19.4 ± 4.3

18.5 ± 3.6

239

4.7

.003

1>3

14.9 ± 5.8

10.5 ± 4.9

13.5 ± 5.5

239

12.7

< .001

1,3>2

2.57

.055

NOT SIG

2.49

.061

NOT SIG

Depressed mood
Nonconsensual sex
Physical abuse
Abuse by romantic partner
Age of first opioid
Yrs since first opioid
Cigarette use
73 (81.1)
47 (69.1)
41 (77.4)
Reproductive Health Outcomes & Behaviors

260

3.6 ± 1.6

3.1 ± 1.6

3.0 ± 1.6

258

34.6 ± 38.2

33.7 ± 36.6

31.5 ± 38.8

254

15.2 ± 25.9

10.9 ± 20.2

6.0 ± 16.9

238

# of pregnancies
% unplanned pregnancies
% pregnancies on BC
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Never missed an appointment for BC
Measure

7 (2.7)
23 (8.7)
7 (2.7)
Hysterectomy or
Using
Not using
BTL (1)
Contraception (2) Contraception (3)
Reproductive Knowledge and Attitudes

261
n

Chi-square or
F-Value

p-value

Sig Mean Contrasts

15.0

.001

2>1

0.86

.423

NOT SIG

3.1

.028

2>1

Important to avoid pregnancy
1.9 ± 1.4

1.3 ± 0.9

1.6 ± 1.0

249

Suboxone use during pregnancy can affect the
fetus

2.1 ± 1.1

2.3 ± 1.4

2.3 ± 1.3

253

Taking Rx painkillers during pregnancy can
affect the fetus

1.7 ± 1.0

1.8 ± 1.2

1.6 ± 1.0

240

1.3 ± 0.7

1.2 ± 0.6

1.2± 0.6

240

1.8 ± 1.0

1.7 ± 1.1

1.6 ± 0.8

238

58.9 ± 17.4

65.7 ± 15.1

59.2 ± 18.3

234

24.4 ± 21.1

34.1 ± 21.6

31.1 ± 24.7

254

4.2 ± 1.2

4.1 ± 1.2

4.1 ± 1.0

256

3.2 ± 1.2

3.5 ± 1.3

2.9 ± 1.2

252

2.4 ± 1.2

2.6 ± 1.4

2.6 ± 1.2

251

3.2 ± 1.3

3.1 ± 1.5

2.9 ± 1.6

254

2.3 ± 1.5

2.2 ± 1.5

2.0 ± 1.4

248

1.8 ± 1.2

1.3 ± 0.8

1.6 ± 0.9

249

2.1 ± 1.1

1.9 ± 1.0

1.9 ± 1.2

249

Painkillers create challenges for pregnancy

Community members are concerned about
women using painkillers during pregnancy

% correct on contraception knowledge

% correct on knowledge of IUDs

Social support
Government makes certain BC is safe
Drug companies don’t care if BC is safe
Will get pregnant regardless of BC use
Can’t stop to use BC when aroused
Using BC is morally wrong
Men are more responsible with BC than
women
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Table 7 – Chi-squared or One-way ANOVA with Bonferroni Post Hoc Test by Current Contraception and Pregnancy Status
(Maximum n = 254)
Measure

Hysterectomy
Using
Not using
Currently
n
Chi-square or
or BTL (1)
Contraception Contraception
Pregnant
F-Value
(2)
(3)
(4)
Frequency (%) or Mean ± Standard Deviation
Health Status & Substance Use

pvalue

Sig Mean
Contrasts

Depressed mood
9.3 ± 2.5

8.5 ± 2.6

9.0 ± 2.6

9.2 ± 2.5

239

1.4

.237

NOT SIG

20.9 ± 6.1

19.4 ± 4.3

18.5 ± 3.6

17.4 ± 4.1

239

4.7

.003

1>3,4

14.9 ± 5.8

10.5 ± 4.9

< .001

1,3>2,4

3.6 ± 1.6

3.1 ± 1.6

2.57

.055

NOT SIG

15.2 ± 25.9

10.9 ± 20.2

6.0 ± 16.9
17.3 ± 26.9
238
2.49
Reproductive Knowledge and Attitudes

.061

NOT SIG

1.9 ± 1.4

1.3 ± 0.9

1.6 ± 1.0

1.3 ± 0.7

1.2 ± 0.6

1.2± 0.6

24.4 ± 21.1

34.1 ± 21.6

31.1 ± 24.7

Age of first opioid
Years since first opioid
13.5 ± 5.5
9.7 ± 3.7
239
12.7
Reproductive Health Outcomes & Behaviors

# of pregnancies
3.0 ± 1.6

3.9 ± 2.7

258

% pregnancies on BC

Important to avoid pregnancy
249

15.0

.001

2>1

1.4 ± 0.8

240

0.86

.423

NOT SIG

25 ± 19.3

254

3.1

.028

2>1

Painkillers create challenges for pregnancy

% correct on knowledge of IUDs
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Appendix A - Contraception Utilization Survey
SOCIODEMOGRAPHICS
Q1 Your birthdate: (MM/DD/YYYY): ______________________________

Q2 What is your residential zip code? ____________________________

Q3 What is your county of residence? ____________________________

Q4 Which best describes you? (Select all that apply)
• American Indian/Alaska Native (1)
• Asian (2)
• Black or African American (3)
• Hispanic/Latino (4)

• Native Hawaiian/Other Pacific Islander (5)
• White (6)
• Other (please specify): (7) _____________

Q5 What is your marital status?
• Single (1)
• Living with romantic partner
(e.g. boyfriend, girlfriend, or fiancé) (2)
• Married (3)

• Separated (4)
• Divorced (5)
• Widowed (6)

Q6 What is the highest level of education you have finished?
• Less than high school (1)
• High school graduate (2)
• Some college (3)
• 2-year college graduate (associates degree) (4)

•
•
•
•

4-year college graduate (bachelor’s degree) (5)
Some graduate school (6)
Graduate degree (7)
Other (please specify): (8) ______________

Q7 Which best describes your current employment status? (Select all that apply)
• Full time (1)
• Student (6)
• Part time (2)
• Retired (7)
• Temporary (3)
• Homemaker (8)
• Unemployed - looking for employment (4)
• Unable to work (9)
• Unemployed - not looking for employment (5)
• Other (please specify): (10) _____________

Q8 Do you have health insurance coverage?
• Private (e.g. BCBS, United, Cigna, Aetna) (1)
• Public (e.g. Medicaid, TennCare) (2)

Q9 What is your household income?
• $0-$10,000 (1)
• $10,001-$20,000 (2)

• No Insurance (3)

• $20,001-$30,000 (3)
• $30,001-$50,000 (4)

Q10 Number of persons living in household? ______________________________

• Over $50,000 (5)
• Don't Know (6)
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Q11 Have you had any difficulties paying your rent, mortgage, or utilities in the past year?
• Yes (1)
• No (2)

Q12 In the past year, have you moved in with family/friends because you’ve no other choice?
• Yes (1)
• No (2)

Q13 Think about the past week. How often have you experienced the following?
Rarely (1) Sometimes(2)

Often (3)

Most of the time (4)

You felt depressed. (1)

•

•

•

•

You felt that everything you did was an effort. (2)

•

•

•

•

You felt hopeful about the future. (3)

•

•

•

•

You were happy. (4)

•

•

•

•

Q14 Would you say that your general health is...?
• Excellent (1)
• Good (3)
• Very Good (2)
• Fair (4)

• Poor (5)

DRUG USE HISTORY & TREATMENT
Q15 When did you first begin Suboxone treatment? (MM/YYYY): ______________________________

Q16 How many times have you done intake for Suboxone or Methadone treatment?______________

Q17 Have you ever used or done any of the following? (Select all that apply)
• Sniffed gasoline, glue, or other substances (1)
• Mescaline (9)
• Drugs with needles or shot up (2)
• Methamphetamine, Amphetamines, other uppers (10)
• Marijuana or hashish (3)
• Benzodiazepines, barbiturates, other tranquilizers, downers
(11)
• Non-medical use of opioids/not as prescribed (4)
• Sedatives or hypnotics (12)
• Cocaine/crack (5)
• Inhalants, poppers, rush, whippets (13)
• Heroin or other opiates (6)
• Other (please specify): (14) __________________
• Nonprescription methadone (7)
• PCP, hallucinogens/psychedelics, LSD, mushrooms (8)

Q18 Which drugs best describe your FIRST use of opioids? (Select all that apply)
• Buprenorphine (1)
• Fentanyl (6)
• Methadone (11)
• Codeine (2)
• Heroin (7)
• Morphine (12)
• Demerol (3)
• Hydrocodone (8)
• Norco (13)
• Dilaudid (4)
• Lorcet (9)
• OxyContin (14)
• Exalgo (5)
• Lortab (10)
• Percocet (15)

• Roxicodone (16)
• Suboxone (17)
• Vicodin (18)
• Other (19)
(specify): ______

Q19 How old were you when you FIRST took this opioid? ______________________________________
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Q20 How did you take your FIRST opioid?
• Swallow (1)
• Sniffing/Snorting (2)

• Injecting/Shooting up (3)
• Other: (4) _________________________

Q21 How did you get your FIRST opioids?
• A family members prescription (1)
• A friend who had the drug (3)
• Your own prescription (2)
• Street contact sold the drug (4)

Q22 Do you use marijuana?
• Yes (1)

• No (2)

Q23 Do you smoke cigarettes?
• Yes (1)

• No (2)

Q24 Do you use smokeless tobacco?
• Yes (1)

• No (2)

Q25 Do you use e-cigarettes?
• Yes (1)

• No (2)

• Other (please specify): (5)
_____________________

PREGNANCY & SEXUAL HEALTH HISTORY
Q26 Last normal menstrual cycle: MM/YYYY (1) ____________________________________________

Q27 Have you been sexually active in the past 12 months?
• Yes (1)

• No (2)

Q28 How many times have you been pregnant? ___________________

Q29 How many of your pregnancies were planned? ___________________

Q30 How many times have you given birth? ___________________

Q31 How many children are living? ___________________

Q32 How many miscarriages have you had? ___________________

Q33 How many abortions have you had? ___________________
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Q34 Have any of your children been in Department of Children's Services' (DCS) custody?
• Yes (1)
• No (2)

Q35 Have you had vaginal sex without a condom in the last 2 years?
• Yes (1)
• No (2)

Q36 Have you ever had sex without giving your consent?
• Yes (1)

• Unsure (3)

• No (2)

Q37 Has your romantic partner physically abused (hit, kicked, slapped, etc.) you in the past year?
• Yes (1)
• No (2)

Q38 Has anyone ever physically abused (hit, kicked, slapped, etc.) you in the past year?
• Yes (1)
• No (2)
BIRTH CONTROL
Q39 Have you ever visited a physician or women's health care clinic for birth control?
• Yes (1)
• No (2)

Q40 Do you use Unity Health Care for your gynecological visits?
• Yes (1)
• If no, where do you go for your women's health needs?
(3) __________________________
• No (2)

Q41 Do you currently use birth control?
• Yes (1)
• No (2)

• No, currently pregnant (3)

Q42 What is your current birth control use? Check all that apply, may choose more than one.
• Currently pregnant (1)
• Rhythm method/Natural Family Planning (12)
• Condoms (2)
• Implant (13)
• Oral contraceptive (pills) (3)
• Vaginal douching (14)
• Emergency birth control or "Plan B" (4)
• None - currently trying to get pregnant (15)
• Patch (5)
• None - do not wish to get pregnant (16)
• Depo (injection) (6)
• None - physically unable to become pregnant (17)
• NuVa ring (ring) (7)
• None - partner had vasectomy (18)
• Withdrawal (pulling out) (8)
• None - tubes tied or had hysterectomy (19)
• Intrauterine Device (IUD) (9)
• None - do not use birth control (20)
• Spermicides (foam, jelly, or cream) (10)
• Other (please specify): (21) ____________
• Diaphragm (11)
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Q43 Which types of birth control have you used within the past 5 years? (Select all that apply)
• Condoms (1)
• Rhythm method/Natural Family Planning (11)
• Oral contraceptive (pills) (2)
• Implant (12)
• Emergency birth control or "Plan B" (3)
• Vaginal douching (13)
• Patch (4)
• None - currently trying to get pregnant (14)
• Depo (injection) (5)
• None - do not wish to get pregnant (15)
• NuVa ring (ring) (6)
• None - physically unable to become pregnant (16)
• Withdrawal (pulling out) (7)
• None - partner had vasectomy (17)
• Intrauterine Device (IUD) (8)
• None - tubes tied or had hysterectomy (18)
• Spermicides (foam, jelly, or cream) (9)
• None - do not use birth control (19)
• Diaphragm (10)
• Other (please specify): (20) ___________
Q44 In the past year, have there been times when you haven’t used birth control because: (Select all that apply)
• You were pregnant (1)
• It is okay if you get pregnant (2)
• In menopause (11)
• You do not think you need to (3)
• Did not have sex with a man (12)
• Missed medical appointments so no prescription (4)
• You do not have a medical provider (13)
• Expensive (5)
• You’ve always used birth control in the past 12
months.(14)
• Difficult to remember to take or have available (6)
•
Partner had vasectomy (15)
• Did not like the birth control you were using (7)
• Had tubes tied or had hysterectomy (16)
• Only occasionally have sex (8)
• No insurance (17)
• Partner did not want you to use birth control (9)
• Other (please specify): (18)___________________
• Safety concerns about birth control (10)

Q45 In the past year, have you missed/not made an appointment for birth control because (Select all that apply):
• Forgot (1)
• Childcare (14)
• Overslept (2)
• Don't know how to cancel appointment (15)
• Sick (3)
• Don't know where to go (16)
• Bad weather (4)
• Prescription necessary (17)
• Afraid of bad news (5)
• Inconvenient (18)
• Had to take care of someone (6)
• Doctor's hours are not convenient (19)
• Afraid of pelvic exam (7)
• Medical person asks uncomfortable questions (20)
• Feel violated by pelvic exam (8)
• Exam is uncomfortable (21)
• Don't like clinic (9)
• Can't get off work or school (22)
• Don't like doctor/nurse practitioner (10)
• You’ve never missed an appointment (23)
• Did not choose doctor/nurse practitioner (11)
• Had tubes tied and/or hysterectomy (24)
• Transportation (12)
• Met with doctor as scheduled in the past 12 mo. (25)
• Cost (13)
• Partner had a vasectomy (26)
• No insurance (27)
• Other (please specify) (28) ________________

Q46 How many times have you gotten pregnant while using birth control? ________________________
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Q47 What type(s) of birth control were you using? (Select all that apply)
• Condoms (1)
• Spermicides (foam, jelly, cream) (8) • None, have tubes tied or had
hysterectomy (14)
• Oral Contraceptive (pills) (2)
• Diaphragm (9)
• None (15)
• Patch (3)
• Rhythm method/Natural Family
Planning (10)
• Other (please specify): (16)
• Depo (injection) (4)
___________________
• Implant (11)
• NuVa ring (ring) (5)
• Vaginal douching (12)
• Withdrawal (pulling out) (6)
• None, partner had vasectomy (13)
• Intrauterine Device (IUD) (7)

KNOWLEDGE & MISCONCEPTIONS
Q48 Please answer the following.
Not at all Slightly likely Quite likely
likely (1)
(2)
(3)
Some people are unable to become pregnant, even if they want to.
Do you believe that you are infertile or will have difficulty getting
pregnant when you want to? (1)

Q49 How much do you agree with the following statements?
Strongly
agree (1)

Somewhat
agree (2)

•

•

•

Neither agree Somewhat
nor disagree (3) disagree (4)

Extremely
likely (4)
•

Strongly
disagree (5)

You are comfortable discussing birth control
with your doctor. (1)

•

•

•

•

•

You are comfortable discussing birth control
with your partner. (2)

•

•

•

•

•

Your partner is supportive of your use of birth
control. (3)

•

•

•

•

•

Your friends support the use of birth control. (4)

•

•

•

•

•

It is important to avoid pregnancy right now. (5)

•

•

•

•

•
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Q50 How much do you agree with the following statements?
Strongly
Somewhat Neither agree Somewhat
disagree (1) disagree (2) nor disagree (3) agree (4)

Strongly
Agree (5)

Whether you use birth control or not, when it’s
your time to get pregnant, it will happen. (1)

•

•

•

•

•

You can't stop to use birth control when aroused.
(2)

•

•

•

•

•

Drug companies don't care if birth control is safe,
they want people to use it so they can make
money.(3)

•

•

•

•

•

The government ensures that birth control
methods are safe before they come onto the
market. (4)

•

•

•

•

•

Using birth control is morally wrong.(5)

•

•

•

•

•

How much do you agree with the following statements?
Strongly
disagree (1)

Somewhat
disagree (2)

Neither agree
nor disagree (3)

Somewhat
agree (4)

Strongly
agree (5)

You have all the information you need to avoid
an unplanned pregnancy. (1)

•

•

•

•

•

You know where to obtain birth control. (2)

•

•

•

•

•

Women enrolled in addiction treatment should
be required by law to use long-lasting birth
control (e.g. Depo or IUD). (3)

•

•

•

•

•

Men and women are equally responsible for
birth control use. (4)

•

•

•

•

•

Men are more responsible in using birth control
than women.(5)

•

•

•

•

•

Q52 How much do you agree with the following statements?
Strongly
agree (1)

Somewhat Neither agree Somewhat Strongly
agree (2) nor disagree (3) disagree (4) disagree (5)

Your partner(s) will not let you use birth control. (1)

•

•

•

•

•

Suboxone use during pregnancy can affect the fetus. (2)

•

•

•

•

•

Taking prescription painkillers during pregnancy can
affect the fetus. (3)

•

•

•

•

•

Community members are concerned about women
using painkillers during pregnancy. (4)

•

•

•

•

•
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Q53 For the following, please state whether you think the statement is TRUE or FALSE.
True
(1)

False (2) I don't know (3)

It is okay to use the same condom more than once. (1)

•

•

•

Condoms have an expiration date. (2)

•

•

•

When using a condom, it is important to leave space at the tip. (3)

•

•

•

It is okay to use petroleum jelly or Vaseline as a lubricant when using latex
condoms. (4)

•

•

•

When using a condom, it is important for the man to pull out right after ejaculation.
(5)

•

•

•

Q54 For the following, please state whether you think the statement is TRUE or FALSE.
True (1)

False (2) I don't know (3)

Wearing two latex condoms will provide extra protection. (1)

•

•

•

Birth control pills are effective even if a woman misses them for two or three days
in a row. (2)

•

•

•

Women should "take a break" from the pill every couple of years. (3)

•

•

•

If a woman is having side effects with one kind of pill, switching to another type of
brand might help. (4)

•

•

•

Birth control pills reduce the chances of certain types of cancer. (5)

•

•

•

Q55 For the following statements, please state whether you think the statement is TRUE or FALSE.
True (1) False (2) I don't know (3)
After a woman stops taking birth control, she is unable to get pregnant
for at least two months. (1)

•

•

•

In order to get birth control, a woman must have a pelvic exam. (2)

•

•

•

A woman can use an IUD, even if she has never had a child. (3)

•

•

•

Woman who use IUDs cannot use tampons (4)

•

•

•

To obtain an IUD, a woman must undergo a surgery (5)

•

•

•
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Q56 For the following statements, please state whether you think the statement is TRUE or FALSE.
True (1) False (2) I don't know (3)
An IUD cannot be felt by a woman's partner during sex. (1)

•

•

•

IUDs can move around in a woman's body (2)

•

•

•

Women using the birth control shot, must get an injection every 3 months. (3)

•

•

•

Women using a vaginal ring, or Nuva Ring, must have it inserted by a doctor or
health care provider every month. (4)

•

•

•

Q57 For the following statements, please state whether you think the statement is TRUE or FALSE.
True (1) False (2) I don't know (3)
Long-acting methods like the implant or IUD cannot be removed early, even if a
woman changes her mind about wanting to get pregnant. (1)

•

•

•

After giving birth, a woman can get pregnant even before she has her first period.
(2)

•

•

•

Douching (washing the vagina) after sex can prevent pregnancy. (3)

•

•

•

A woman who is still breast feeding cannot get pregnant. (4)

•

•

•

Q58 For the following statements, please state whether you think the statement is TRUE or FALSE.
True
False (2) I don't know (3)
(1)
Pregnancy is less likely to occur if a couple has sex standing up. (1)

•

•

•

The only way to completely prevent pregnancy is by not having sex. (2)

•

•

•

During a woman's monthly cycle, there are certain days when she is more likely to
become pregnant if she has sex. (3)

•

•

•

Use of opioids or other drugs during pregnancy can create challenges for the
pregnancy or the unborn child. (4)

•

•

•

